Holen Sie sich die Stockscreener-App
1.04
2.78%
-0.04
Schlusskurs vom Vortag:
$1.08
Offen:
$1.08
24-Stunden-Volumen:
98,594
Relative Volume:
0.26
Marktkapitalisierung:
$3.21M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-3.12M
KGV:
-0.216
EPS:
-4.8149
Netto-Cashflow:
$-2.69M
1W Leistung:
-11.02%
1M Leistung:
-21.05%
6M Leistung:
-41.99%
1J Leistung:
-70.67%
1-Tages-Spanne:
$0.98
$1.08
1-Wochen-Bereich:
$0.98
$1.19
52-Wochen-Spanne:
$0.98
$17.75
180 Life Sciences Corp Stock (ATNF) Company Profile
Firmenname
180 Life Sciences Corp
Sektor
Branche
Telefon
650-507-0669
Adresse
3000 EL CAMINO REAL, PALO ALTO
Vergleichen Sie ATNF mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ATNF
180 Life Sciences Corp
|
1.0466 | 3.21M | 0 | -3.12M | -2.69M | -4.8149 |
|
VRTX
Vertex Pharmaceuticals Inc
|
510.91 | 130.68B | 11.02B | -535.60M | -978.00M | -2.20 |
|
REGN
Regeneron Pharmaceuticals Inc
|
670.03 | 74.97B | 14.20B | 4.41B | 3.54B | 38.28 |
|
ARGX
Argen X Se Adr
|
602.20 | 36.08B | 2.19B | 833.04M | -1.28B | 12.71 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
243.01 | 31.19B | 2.25B | -278.16M | -42.59M | -2.17 |
|
ONC
Beigene Ltd Adr
|
259.62 | 27.56B | 3.32B | -860.46M | -1.04B | -8.32 |
180 Life Sciences Corp Stock (ATNF) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2021-09-15 | Eingeleitet | Maxim Group | Buy |
180 Life Sciences Corp Aktie (ATNF) Neueste Nachrichten
ATNF stock touches 52-week low at $1.1 amid market fluctuations - Investing.com
Contract wins and repeat business fuel progress at life sciences company - The Business Desk
180 Life Sciences’ (ATNF) “Sell (E+)” Rating Reiterated at Weiss Ratings - Defense World
Layoff Tracker: Atea Pharmaceuticals Cuts 25% of Workforce - BioSpace
180 Life Sciences Corp. (NASDAQ:ATNF) Short Interest Down 50.4% in February - Defense World
Short Interest in ArrowMark Financial Corp. (NASDAQ:BANX) Expands By 62.6% - Defense World
American Rebel Holdings, Inc. (NASDAQ:AREB) Sees Large Growth in Short Interest - Defense World
ATNF stock touches 52-week low at $1.14 amid market shifts - Investing.com India
Global Dupuytrens Disease Market Deep Research 2025-2032 | Endo - openPR
180 Life Sciences Appoints New Chief Accounting Officer - TipRanks
180 Life Sciences (NASDAQ:ATNF) Given “Sell (E+)” Rating at Weiss Ratings - Defense World
TURN180 Degree Capital Corp Latest Stock News & Market Updates - StockTitan
180 Life Sciences Corp. modifies former CEO's exit terms - MSN
180 Life Sciences Corp. modifies former CEO's exit terms By Investing.com - Investing.com Canada
180 Life Sciences Appoints New CEO Amid Leadership Changes - TipRanks
Anavex Q1 2025 Earnings: Strategic Growth Updates Coming February 12 - StockTitan
180 Life Sciences (NASDAQ:ATNF) Earns “Sell (E+)” Rating from Weiss Ratings - Defense World
180 Life Sciences Corp. Announces the Appointment of Stephen Shoemaker to Board of Directors - ACCESS Newswire
Sai Life Sciences Shares Continue To Decline, Slumps Over 11% In A Week Despite Expansion Plans - Free Press Journal
180 Life Sciences Corp. Retains Senior Technology Consultant and Commences Gaming Technology Platform Integration - ACCESS Newswire
180 Life Sciences Corp. Regains Full Compliance with Nasdaq Continued Listing Rules - ACCESS Newswire
180 Life Sciences Corp. Regains Compliance with Nasdaq's Minimum Stockholders' Equity Rule and Expands into the Global iGaming Sector - ACCESS Newswire
180 Life Sciences Corp. Announces Pricing of $2.9 Million Registered Direct Offering and Concurrent Private Placement Priced At-The-Market Under NASDAQ Rules - ACCESS Newswire
Anavex Life Sciences Stock Skyrockets 95% in 3 Months: Here's Why - Nasdaq
180 Life Sciences (NASDAQ:ATNF) Earns Sell (E+) Rating from Weiss Ratings - Defense World
Athena Bitcoin Global Announces Appointment of Omar Jimenez as Chief Financial Officer - ACCESS Newswire
Pre-market Movers: AVGR, TIVC, ATNF, SLGL... - RTTNews
Here are 71 Mass. life science firms presenting at J.P. Morgan - The Business Journals
180 Life Sciences to Raise $2.9M as It Shifts Focus to iGaming - GamblingNews.com
180 Life Sciences Corp. expands stock incentive plan - Investing.com India
180 Life Sciences Doubles Down on iGaming with $2.9M Fundraising Effort - Real Money Gambling News
180 Life Sciences Announces Key Proposals and Director Elections - TipRanks
US biotech firm announces $2.9m stock offering amid pivot to iGaming - NEXT.io
Stock offering fuels company's leap to iGaming - Silicon Valley Business Journal
180 Life Sciences Corp. Announces Pricing of $2.9 Million Registered Direct Offering and Concurrent Private Placement Priced At-The-Market under NASDAQ Rules - Marketscreener.com
Short Interest in 180 Life Sciences Corp. (NASDAQ:ATNF) Expands By 148.1% - Defense World
Stock market news: Siyata Mobile -90.00%, PainReform -29.18% among biggest losers during mid day trading - Business Upturn
Stock market today: Siyata Mobile -89.40%, Millennium Group International -27.94% among biggest losers in early trading - Business Upturn
180 Life Sciences announces $2.9 million securities offering - Investing.com
180 Life Sciences (ATNF) Raises $2.9M in Direct Offering, Pivots to Entertainment & iGaming - StockTitan
Alector (ALEC) Stock Dips Amid Mixed Analyst Ratings - GuruFocus.com
180 Life Sciences Corp. Announces Board Changes - Marketscreener.com
180 Life Sciences Corp. Announces Executive Changes - Marketscreener.com
180 Life Sciences Corp. announces CFO resignation - Investing.com India
180 Life Sciences CFO Omar Jimenez Resigns - TipRanks
180 Life Sciences Corp. announces CFO resignation By Investing.com - Investing.com UK
XGEN Venture Announces Final Closing of €180M ($190M) Life Sciences Fund - Yahoo Finance
Sai Life Sciences IPO listing date: Check objectives, subscription and other key details ahead of debut - Upstox
180 Life Sciences Regains Nasdaq Compliance, Advances Strategic Pivot into iGaming Tech - StockTitan
Sai Life Sciences IPO analysis - Value Research Online
ChromaDex maintains Buy rating on recent agreement - Investing.com
Finanzdaten der 180 Life Sciences Corp-Aktie (ATNF)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.28%
0.80%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):